1. Haplotype-resolved and integrated genome analysis of the cancer cell line HepG2
   Bo Zhou et al, 2019, Nucleic Acids Research CrossRef
2. Targeting the Oncogenic TBX2 Transcription Factor With Chromomycins
   Bianca Del B. Sahm et al, 2020, Frontiers in Chemistry CrossRef
3. PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma
   Alex Stanley Balraj et al, 2024, Technology in Cancer Research & Treatment CrossRef
4. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
   Zeda Zhang et al, 2020, Cancer Cell CrossRef
5. Regulation of otocyst patterning by Tbx2 and Tbx3 is required for inner ear morphogenesis in the mouse
   Marina Kaiser et al, 2021, Development CrossRef
6. Unmasking Intra-Tumoral Heterogeneity and Clonal Evolution in NF1-MPNST
   Chang-In Moon et al, 2020, Genes CrossRef
7. Ras and Wnt Interaction Contribute in Prostate Cancer Bone Metastasis
   Shian-Ren Lin et al, 2020, Molecules CrossRef
8. Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer
   Nishat Manzar et al, 2023, Seminars in Cancer Biology CrossRef
9. Expression and prognosis analysis of TBX2 subfamily in human lung carcinoma
   Rui Mi et al, 2024, Discover Oncology CrossRef
10. Role of T‐box genes in cancer, epithelial‐mesenchymal transition, and cancer stem cells
    Gengle Niu et al, 2022, Journal of Cellular Biochemistry CrossRef
11. Contrasting functions of the epithelial‑stromal interaction 1 gene, in human oral and lung squamous cell cancers
    Mengmeng Fan et al, 2021, Oncology Reports CrossRef
12. DNA demethylation agent 5azadC downregulates HPV16 E6 expression in cervical cancer cell lines independently of TBX2 expression
    Jerome Perrard et al, 2019, Oncology Letters CrossRef